Dr Shruja P Patel, MD | |
25314 Kingsland Blvd, Katy, TX 77494-7254 | |
(832) 508-6632 | |
(832) 437-1640 |
Full Name | Dr Shruja P Patel |
---|---|
Gender | Female |
Speciality | Family Practice |
Experience | 12 Years |
Location | 25314 Kingsland Blvd, Katy, Texas |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1467708883 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | BP10043564 (Texas) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Memorial Hermann Katy Hospital | Katy, TX | Hospital |
Houston Methodist West Hospital | Houston, TX | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Shruja Patel Mdpa | 6507297298 | 2 |
News Archive
A collaborative study led by Monash University's Biomedicine Discovery Institute and the Olivia Newton-John Cancer Research Institute has uncovered new markers (HLA-associated peptides) that are uniquely present on melanoma tumours and could pave the way for therapeutic vaccines to be developed in the fight against melanoma.
A New York Times editorial reflects on "a strong executive order aimed at ending human trafficking activities by government contractors and subcontractors," announced by President Obama on September 25 "in a passionate address on the issue ... at the Clinton Global Initiative."
Foreign objects - glass splinters, for example - that find their way into foods can be hazardous to consumers.
Furiex Pharmaceuticals, Inc. today confirmed that Takeda Global Research & Development Centre (Europe) Ltd. received confirmation on the acceptance of the submission of a Marketing Authorization Application, or MAA, from the European Medicines Agency for alogliptin, a selective dipeptidyl peptidase IV, or DPP-4, inhibitor for the treatment of type 2 diabetes.
› Verified 8 days ago
Entity Name | Shruja Patel Mdpa |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1669006771 PECOS PAC ID: 6507297298 Enrollment ID: O20200513001643 |
News Archive
A collaborative study led by Monash University's Biomedicine Discovery Institute and the Olivia Newton-John Cancer Research Institute has uncovered new markers (HLA-associated peptides) that are uniquely present on melanoma tumours and could pave the way for therapeutic vaccines to be developed in the fight against melanoma.
A New York Times editorial reflects on "a strong executive order aimed at ending human trafficking activities by government contractors and subcontractors," announced by President Obama on September 25 "in a passionate address on the issue ... at the Clinton Global Initiative."
Foreign objects - glass splinters, for example - that find their way into foods can be hazardous to consumers.
Furiex Pharmaceuticals, Inc. today confirmed that Takeda Global Research & Development Centre (Europe) Ltd. received confirmation on the acceptance of the submission of a Marketing Authorization Application, or MAA, from the European Medicines Agency for alogliptin, a selective dipeptidyl peptidase IV, or DPP-4, inhibitor for the treatment of type 2 diabetes.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Shruja P Patel, MD 25314 Kingsland Blvd, Katy, TX 77494-7254 Ph: (832) 508-6632 | Dr Shruja P Patel, MD 25314 Kingsland Blvd, Katy, TX 77494-7254 Ph: (832) 508-6632 |
News Archive
A collaborative study led by Monash University's Biomedicine Discovery Institute and the Olivia Newton-John Cancer Research Institute has uncovered new markers (HLA-associated peptides) that are uniquely present on melanoma tumours and could pave the way for therapeutic vaccines to be developed in the fight against melanoma.
A New York Times editorial reflects on "a strong executive order aimed at ending human trafficking activities by government contractors and subcontractors," announced by President Obama on September 25 "in a passionate address on the issue ... at the Clinton Global Initiative."
Foreign objects - glass splinters, for example - that find their way into foods can be hazardous to consumers.
Furiex Pharmaceuticals, Inc. today confirmed that Takeda Global Research & Development Centre (Europe) Ltd. received confirmation on the acceptance of the submission of a Marketing Authorization Application, or MAA, from the European Medicines Agency for alogliptin, a selective dipeptidyl peptidase IV, or DPP-4, inhibitor for the treatment of type 2 diabetes.
› Verified 8 days ago
Dr. Shamim Ali, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 707 S Fry Rd, Suite 360, Katy, TX 77450 Phone: 281-599-9979 Fax: 281-599-3540 | |
Severino Pimentel, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 21304 Provincial Blvd, Katy, TX 77450 Phone: 281-206-8280 Fax: 281-206-8285 | |
Quyen Trinh, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 21770 Kingsland Blvd, Katy, TX 77450 Phone: 281-646-0740 Fax: 281-646-0743 | |
Dr. Molly Magdalene Nakyonyi-ntwatwa, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2510 W Grand Pkwy N, Katy, TX 77449 Phone: 713-442-4222 | |
Behrooz Saffari, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 23923 Cinco Ranch Blvd, Katy, TX 77494 Phone: 713-486-5300 | |
Eric Samuel Colletti, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 21700 Kingsland Blvd Ste 201, Katy, TX 77450 Phone: 281-398-7954 Fax: 281-578-4912 | |
Yanielka Cordova Garcia, APRN Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 22611 Cremona Village Trl, Katy, TX 77449 Phone: 346-970-9490 |